Reports / Rheumatology Reports
Rheumatology Reports
Targeted biologics, the recent emergence of innovative new oral therapies and the arrival of biosimilars will continue to fuel monumental shifts in the way patients with auto-immune disorders are managed.
Rapid turnaround monitor for highly dynamic healthcare segments
Retrospective analysis of 1,000+/- patient charts
-
Ankylosing Spondylitis & Non-Radiographic Axial Spondyloarthritis US
-
Biologic/Small Molecule Switching in Psoriatic Arthritis US
-
Biologic/JAK Switching in Rheumatoid Arthritis US
-
Biologic/JAK Switching in Rheumatoid Arthritis EU
Learn more about our work in the rheumatology space.